1.Renal growth slope in children with congenital and acquired solitary functioning kidneys
Seung Myeon CHOI ; Hyun Joo SHIN ; Haesung YOON ; Myeongjee LEE ; Yong Seung LEE ; Sang Won HAN ; Mi-Jung LEE
Ultrasonography 2021;40(3):357-365
Purpose:
This study aimed to analyze the renal growth slope in children with congenital and acquired solitary functioning kidneys.
Methods:
This retrospective study included all renal ultrasonography examinations performed in children in the agenesis, multicystic dysplastic kidney (MCDK), or nephrectomy group between September 2002 and February 2019. We reviewed the images and recorded the contralateral kidney size only when there was no focal lesion. Linear mixed model or piecewise linear mixed model analyses with a time point of 24 months of age were performed.
Results:
There were 132 patients, including 26 patients in the agenesis group, 35 in the MCDK group, and 71 in the nephrectomy group. The nephrectomy group showed the largest baseline kidney size (7.4 cm vs. 5.3 cm in the agenesis group [P<0.001] and 5.2 cm in the MCDK group [P<0.001]) and the smallest overall growth slope (0.04 cm/mo vs. 0.06 cm/mo in the agenesis group [P=0.004] and 0.07 cm/mo in the MCDK group [P<0.001]). However, considering the time point of 24 months for reaching adult renal function, there were significant changes in slope, from 0.1 cm/mo before 24 months of age to 0.03 cm/mo after 24 months of age in all three groups (P<0.001), without a significant difference among the groups.
Conclusion
Significant changes were found in the renal growth slope before and after 24 months of age, with no significant difference between congenital and acquired solitary functioning kidneys.
2.Infection Rate of Chlamydia pneumoniae in Patients with Chronic Cough.
Seung Yeon CHUN ; Kwon Oh PARK ; Yong Bum PARK ; Jeong Hee CHOI ; Jae Young LEE ; Eun Kyung MO ; Sung Hoon PARK ; Cheol Hong KIM ; Chang Youl LEE ; Yong Il HWANG ; Seung Hun JANG ; Tae Rim SHIN ; Sang Myeon PARK ; Dong Gyu KIM ; Myung Goo LEE ; In Gyu HYUN ; Ki Suck JUNG
Tuberculosis and Respiratory Diseases 2010;69(6):426-433
BACKGROUND: Persistent cough has recently been found to be associated with Chlamydia pneumoniae infection. We aimed to investigate the infection rate of C. pneumonia in adult patients with chronic cough. METHODS: We recruited 68 patients with persistent cough lasting in excess of 3 weeks, who visited Kangdong Sacred Heart Hospital from January 2005 to August 2005. On the first visit, chest and paranasal sinuses radiography, skin prick test of common allergens, and induced sputum samples for C. pneumoniae were performed in all of patients. Further evaluation for diagnosis included a methacholine provocation test and eosinophil counts in induced sputum. RESULTS: The most common cause of chronic cough was upper airway cough syndrome (UACS) (26.5%), followed by eosinophilic bronchitis (20.6%) and cough variant asthma (16.2%). Idiopathic chronic cough was the cause in 33.8% of patients. The mean duration of cough was 11.7 months. C. pneumoniae was isolated by polymerase chain reaction (PCR) from one patient who had upper respiratory air way syndrome. CONCLUSION: Chlamydia pneumoniae appears to have a minor role as a cause of chronic cough in patients.
Adult
;
Allergens
;
Asthma
;
Bronchitis
;
Chlamydia
;
Chlamydia Infections
;
Chlamydophila pneumoniae
;
Cough
;
Eosinophils
;
Heart
;
Humans
;
Methacholine Chloride
;
Paranasal Sinuses
;
Pneumonia
;
Polymerase Chain Reaction
;
Skin
;
Sputum
;
Thorax
3.Bronchoscopic Ethanolamine Injection Therapy in Patients with Persistent Air Leak from Chest Tube Drainage.
Ah Leum LIM ; Cheol Hong KIM ; Yong Il HWANG ; Chang Youl LEE ; Jeong Hee CHOI ; Taerim SHIN ; Yong Bum PARK ; Seung Hun JANG ; Sang Myeon PARK ; Dong Gyu KIM ; Myung Goo LEE ; In Gyu HYUN ; Ki Suck JUNG ; Ho Seung SHIN
Tuberculosis and Respiratory Diseases 2012;72(5):441-447
BACKGROUND: Chest tube drainage (CTD) is an indication for the treatment of pneumothorax, hemothroax and is used after a thoracic surgery. But, in the case of incomplete lung expansion, and/or persistent air leak from CTD, medical or surgical thoracoscopy or, if that is unavailable, limited thoracotomy, should be considered. We evaluate the efficacy of bronchoscopic injection of ethanolamine to control the persistent air leak in patients with CTD. METHODS: Patients who had persistent or prolonged air leak from CTD were included, consecutively. We directly injected 1.0 mL solution of 5% ethanolamine oleate into a subsegmental or its distal bronchus, where it is a probable air leakage site, 1 to 21 times using an injection needle through a fiberoptic bronchoscope. RESULTS: A total of 15 patients were enrolled; 14 cases of spontaneous pneumothorax [idiopathic 9, chronic obstructive pulmonary disease (COPD) 3, post-tuberculosis 2] and one case of empyema associated with broncho-pleural fistula. Of these, five were patients with persistent air leak from CTD, just after a surgical therapy, wedge resection with plication for blebs or bullae. With an ethanolamine injection therapy, 12 were successful but three (idiopathic, COPD and post-tuberculosis) failed, and were followed by a surgery (2 cases) or pleurodesis (1 case). Some adverse reactions, such as fever, chest pain and increased radiographic opacities occurred transiently, but resolved without any further events. With success, the time from the procedure to discharge was about 3 days (median). CONCLUSION: Bronchoscopic ethanolamine injection therapy may be partially useful in controlling air leakage, and reducing the hospital stay in patients with persistent air leak from CTD.
Blister
;
Bronchi
;
Bronchoscopy
;
Chest Pain
;
Chest Tubes
;
Drainage
;
Empyema
;
Ethanolamine
;
Fever
;
Fistula
;
Humans
;
Length of Stay
;
Lung
;
Needles
;
Oleic Acid
;
Oleic Acids
;
Pleurodesis
;
Pneumothorax
;
Pulmonary Disease, Chronic Obstructive
;
Thoracic Surgery
;
Thoracoscopy
;
Thoracotomy
;
Thorax
4.A Trial of Aerosolized Colistin for the Treatment of Nosocomial Pneumonia due to Multidrug-resistant Acinetobacter baumannii.
Changhwan KIM ; Dong Gyu KIM ; Hye Ryun KANG ; Jeong Hee CHOI ; Chang Youl LEE ; Yong Il HWANG ; Tae Rim SHIN ; Sang Myeon PARK ; Yong Bum PARK ; Jae Young LEE ; Seung Hun JANG ; Cheol Hong KIM ; Eun Kyung MO ; Myung Goo LEE ; In Gyu HYUN ; Ki Suck JUNG ; Young Jin CHOI ; Jae Woong LEE
Tuberculosis and Respiratory Diseases 2008;64(2):102-108
BACKGROUND: Recently, multidrug-resistant (MDR) A. baumannii has been implicated for a significant proportion of nosocominal pneumonia in many intensive care units (ICUs), and its acquisition may increase mortality and the length of stay in the ICU. Aerosolized colistin has been successfully used in patients with cystic fibrosis, but there is a lack of data regarding the use of aerosolized colistin in patients with nosocomial pneumonia. METHODS: We conducted the present study to assess the effectiveness of aerosolized colistin for the treatment of MDR A. baumannii nosocomial pneumonia. We retrospectively reviewed the medical records of 10 patients who had been hospitalized in the medical ICU and had received aerosolized colistin as a therapy for MDR A. baumannii pneumonia. RESULTS: The mean duration of aerosolized colistin therapy was 12.7+/-2.4 days. Nine (90%) of 10 patients showed a favorable response to the therapy. Follow-up cultures were available for all patients, and the responsible pathogen was completely eradicated. One patient suffered from bronchospasm, which resolved after treatment with nebulized salbutamol. CONCLUSION: Our results corroborate previous reports that aerosolized colistin may be an effective and safe choice for the treatment of nosocomial pneumonia caused by MDR A. baumannii. Larger prospective controlled clinical studies are warranted to validate further the effectiveness and safety of aerosolized colistin therapy.
Acinetobacter
;
Acinetobacter baumannii
;
Albuterol
;
Bronchial Spasm
;
Colistin
;
Cystic Fibrosis
;
Follow-Up Studies
;
Humans
;
Intensive Care Units
;
Length of Stay
;
Medical Records
;
Pneumonia
;
Retrospective Studies
5.Application of a New Spirometric Reference Equation and Its Impact on the Staging of Korean Chronic Obstructive Pulmonary Disease Patients.
Yong Il HWANG ; Eun Ji KIM ; Chang Youl LEE ; Sunghoon PARK ; Jeong Hee CHOI ; Yong Bum PARK ; Seung Hun JANG ; Cheol Hong KIM ; Tae Rim SHIN ; Sang Myeon PARK ; Dong Gyu KIM ; Myung Goo LEE ; In Gyu HYUN ; Ki Suck JUNG
Yonsei Medical Journal 2012;53(2):363-368
PURPOSE: A new spirometric reference equation was recently developed from the first national chronic obstructive pulmonary disease (COPD) survey in Korea. However, Morris' equation has been preferred for evaluating spirometric values instead. The objective of this study was to evaluate changes in severity staging in Korean COPD patients by adopting the newly developed Korean equation. MATERIALS AND METHODS: We evaluated the spirometric data of 441 COPD patients. The presence of airflow limitation was defined as an observed post-bronchodilator forced expiratory volume in one second/forced vital capacity (FEV1/FVC) less than 0.7, and the severity of airflow limitation was assessed according to GOLD stages. Spirometric values were reassessed using the new Korean equation, Morris' equation and other reference equations. RESULTS: The severity of airflow limitation was differently graded in 143 (32.4%) patients after application of the new Korean equation when compared with Morris' equation. All 143 patients were reallocated into more severe stages (49 at mild stage, 65 at moderate stage, and 29 at severe stage were changed to moderate, severe and very severe stages, respectively). Stages according to other reference equations were changed in 18.6-49.4% of the patients. CONCLUSION: These results indicate that equations from different ethnic groups do not sufficiently reflect the airflow limitation of Korean COPD patients. The Korean reference equation should be used for Korean COPD patients in order to administer proper treatment.
Adult
;
Aged
;
Aged, 80 and over
;
Asian Continental Ancestry Group
;
Female
;
Humans
;
Korea
;
Male
;
Middle Aged
;
Pulmonary Disease, Chronic Obstructive/*diagnosis/pathology
;
Retrospective Studies
;
Spirometry/*methods
6.Incidence of Immunoglobulin G Subclass Deficiencies in Patients with Bronchiectasis and the Clinical Characteristics of Patients with Immunoglobulin G Subclass Deficiency and Bronchiectasis.
Chang Hwan KIM ; Dong Gyu KIM ; Sung Hoon PARK ; Jeong Hee CHOI ; Chang Youl LEE ; Yong Il HWANG ; Tae Rim SHIN ; Sang Myeon PARK ; Yong Bum PARK ; Jae Young LEE ; Seung Hun JANG ; Cheol Hong KIM ; Eun Kyung MO ; Myung Goo LEE ; In Gyu HYUN ; Ki Suck JUNG
Tuberculosis and Respiratory Diseases 2009;66(4):295-299
BACKGROUND: There are various etiologies causing bronchiectasis, but the cases without definite causes account for a quite high proportion. It is also uncertain that immunoglobulin G subclass deficiency (IgGSD) is associated with bronchiectasis. Therefore, we tried to measure the frequency of IgGSD in patients with bronchiectasis of unclear etiology, and to observe the clinical features of those patients with bronchiectasis and IgGSD. METHODS: For the outpatients of a university hospital who were diagnosed as bronchiectasis by chest CT, we produced comprehensive history taking and physical examinations, and finally selected 31 patients with bronchiectasis of unclear etiology. RESULTS: Two patients had total immunoglobulin G deficiency. The frequency of IgGSD was comparatively high (n=14). When we compared IgGSD group to normal immunoglobulin G subclass group, there were no significant differences in sex, age, and the frequency of sinusitis, bronchial asthma, and the abnormal lung function. CONCLUSION: In cases of bronchiectasis without definite causes, it can be considered to measure the level of immunoglobulin G subclass. It is also probably worthwhile to further evaluate the relationship between IgGSD and bronchiectasis.
Asthma
;
Bronchiectasis
;
Humans
;
Immunoglobulin G
;
Immunoglobulins
;
Incidence
;
Lung
;
Outpatients
;
Physical Examination
;
Sinusitis
;
Thorax
7.Semi-quantitative Procalcitonin Assay in Critically ill Patients with Respiratory infections.
Ji Youn KIM ; Cheol Hong KIM ; Sunghoon PARK ; Chang Youl LEE ; Yong Il HWANG ; Jeong Hee CHOI ; Taerim SHIN ; Yong Bum PARK ; Seung Hun JANG ; Jae Young LEE ; Sang Myeon PARK ; Dong Gyu KIM ; Myung Goo LEE ; In Gyu HYUN ; Ki Suck JUNG
Tuberculosis and Respiratory Diseases 2009;67(3):205-211
BACKGROUND: Serum procalcitonin level has been considered prognostic during sepsis and septic shock. We investigated the significance of procalcitonin in critically ill patients with respiratory infections. METHODS: The patients who had radiographically diagnosed diffuse lung infiltrations were enrolled on a prospective basis. Bronchoalveolar lavage (BAL) fluid for the purpose of quantitative cultures (> or =10(4) cfu/mL) was obtained from all patients. Serum procalcitonin levels determined by PCT-Q kit were measured on BAL day and classified as follows; <0.5 ng/mL, 0.5~2.0 ng/mL, 2.0~10.0 ng/mL and >10.0 ng/mL. We analyzed the patient's characteristics according to outcome; favorable or unfavorable, defined as death. RESULTS: Patients from the following categories were included: medical 17 (47.2%), surgical 9 (25%), and burned 10 (27.8%). APACHE II scores on admission to intensive care unit were 11.5+/-6.89 and 11 (30.6%) had unfavorable outcomes. A procalcitonin level > or =0.5 ng/mL was in 17 (47.2%) of all. On univariate analysis, the frequencies of burn injury, mechanical ventilation, multiple organ failure, and a procalcitonin level > or =0.5 ng/mL were more often increased in patients with unfavorable outcomes than in those with favorable outcomes (p<.05). Also, a higher procalcitonin range and ventilator-associated pneumonia (VAP) were more closely associated with an unfavorable outcome (p<.05). However in multivariate analysis, a strong predictor of unfavorable outcome was burn injury (p<.05). A procalcitonin level > or =0.5 ng/mL was more sensitive in predicting VAP than unfavorable outcome. CONCLUSION: A higher procalcitonin level seems to be associated with VAP, but further study is required to know that procalcitonin would be a prognostic marker in critically ill patients with respiratory infections.
APACHE
;
Bronchoalveolar Lavage
;
Burns
;
Calcitonin
;
Critical Illness
;
Humans
;
Intensive Care Units
;
Lung
;
Multiple Organ Failure
;
Multivariate Analysis
;
Pneumonia, Ventilator-Associated
;
Prospective Studies
;
Protein Precursors
;
Respiration, Artificial
;
Respiratory Tract Infections
;
Sepsis
;
Shock, Septic
8.A Study to Validate the Pretest Probability of Malignancy in Solitary Pulmonary Nodule.
Joo Hyun JANG ; Sung Hoon PARK ; Jeong Hee CHOI ; Chang Youl LEE ; Yong Il HWANG ; Tae Rim SHIN ; Yong Bum PARK ; Jae Young LEE ; Seung Hun JANG ; Cheol Hong KIM ; Sang Myeon PARK ; Dong Gyu KIM ; Myung Goo LEE ; In Gyu HYUN ; Ki Suck JUNG
Tuberculosis and Respiratory Diseases 2009;67(2):105-112
BACKGROUND: Solitary pulmonary nodules (SPN) are encountered incidentally in 0.2% of patients who undergo chest X-ray or chest CT. Although SPN has malignant potential, it cannot be treated surgically by biopsy in all patients. The first stage is to determine if patients with SPN require periodic observation and biopsy or resection. An important early step in the management of patients with SPN is to estimate the clinical pretest probability of a malignancy. In every patient with SPN, it is recommended that clinicians estimate the pretest probability of a malignancy either qualitatively using clinical judgment or quantitatively using a validated model. This study examined whether Bayesian analysis or multiple logistic regression analysis is more predictive of the probability of a malignancy in SPN. METHODS: From January 2005 to December 2008, this study enrolled 63 participants with SPN at the Kangnam Sacred Hospital. The accuracy of Bayesian analysis and Bayesian analysis with a FDG-PET scan, and Multiple logistic regression analysis was compared retrospectively. The accurate probability of a malignancy in a patient was compared by taking the chest CT and pathology of SPN patients with <30 mm at CXR incidentally. RESULTS: From those participated in study, 27 people (42.9%) were classified as having a malignancy, and 36 people were benign. The result of the malignant estimation by Bayesian analysis was 0.779 (95% confidence interval [CI], 0.657 to 0.874). Using Multiple logistic regression analysis, the result was 0.684 (95% CI, 0.555 to 0.796). This suggests that Bayesian analysis provides a more accurate examination than multiple logistic regression analysis. CONCLUSION: Bayesian analysis is better than multiple logistic regression analysis in predicting the probability of a malignancy in solitary pulmonary nodules but the difference was not statistically significant.
Bayes Theorem
;
Biopsy
;
Humans
;
Judgment
;
Logistic Models
;
Retrospective Studies
;
Solitary Pulmonary Nodule
;
Thorax
9.Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.
Soon Hyun AHN ; Hyun Jun HONG ; Soon Young KWON ; Kee Hwan KWON ; Jong Lyel ROH ; Junsun RYU ; Jun Hee PARK ; Seung Kuk BAEK ; Guk Haeng LEE ; Sei Young LEE ; Jin Choon LEE ; Man Ki CHUNG ; Young Hoon JOO ; Yong Bae JI ; Jeong Hun HAH ; Minsu KWON ; Young Min PARK ; Chang Myeon SONG ; Sung Chan SHIN ; Chang Hwan RYU ; Doh Young LEE ; Young Chan LEE ; Jae Won CHANG ; Ha Min JEONG ; Jae Keun CHO ; Wonjae CHA ; Byung Joon CHUN ; Ik Joon CHOI ; Hyo Geun CHOI ; Kang Dae LEE
Clinical and Experimental Otorhinolaryngology 2017;10(1):1-43
Korean Society of Thyroid-Head and Neck Surgery appointed a Task Force to develop clinical practice guidelines for the surgical treatment of laryngeal cancer. This Task Force conducted a systematic search of the EMBASE, MEDLINE, Cochrane Library, and KoreaMed databases to identify relevant articles, using search terms selected according to the key questions. Evidence-based recommendations were then created on the basis of these articles. An external expert review and Delphi questionnaire were applied to reach consensus regarding the recommendations. The resulting guidelines focus on the surgical treatment of laryngeal cancer with the assumption that surgery is the selected treatment modality after a multidisciplinary discussion in any context. These guidelines do not, therefore, address non-surgical treatment such as radiation therapy or chemotherapy. The committee developed 62 evidence-based recommendations in 32 categories intended to assist clinicians during management of patients with laryngeal cancer and patients with laryngeal cancer, and counselors and health policy-makers.
Advisory Committees
;
Consensus
;
Counseling
;
Drug Therapy
;
Glottis
;
Humans
;
Laryngeal Neoplasms*
;
Neck*